SLC34A2 and neoplasm: Our computational analysis showed that the SLC34A2 gene was upregulated in 15 tumor types when compared to pooled GTEx control group, especially in OV, THCA, and LUAD, whereas it was downregulated in 10, including COAD and BLCA.